Archives of Clinical Infectious Diseases

Published by: Kowsar

Candida auris: A New Emerging Fungal Monster

Omid Raiesi 1 , * , Hajar Shabandoust 2 , Muhammad Getso 1 , Vahid Raissi 1 and Ali Akbar Rezaei 3
Authors Information
1 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Parasitology and Mycology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
3 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran
Article information
  • Archives of Clinical Infectious Diseases: 14 (2); e70741
  • Published Online: March 12, 2019
  • Article Type: Review Article
  • Received: April 28, 2018
  • Revised: January 4, 2019
  • Accepted: January 20, 2019
  • DOI: 10.5812/archcid.70741

To Cite: Raiesi O, Shabandoust H, Getso M, Raissi V, Rezaei A A. Candida auris: A New Emerging Fungal Monster, Arch Clin Infect Dis. Online ahead of Print ; 14(2):e70741. doi: 10.5812/archcid.70741.

Abstract
Copyright © 2019, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Who Is at Risk?
3. Mode of Transmission <i>Candida auris</i>
4. <i>Candida auris</i> Virulence Factors
5. Clinical Conditions and Mortality
6. Diagnosis of a <i>Candida auris</i> Infection
7. Decolonization
8. Drug Resistance
9. Case Reports
10. Conclusions
Footnotes
References
  • 1. Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic candida species. mSphere. 2016;1(4). doi: 10.1128/mSphere.00189-16. [PubMed: 27547827]. [PubMed Central: PMC4990711].
  • 2. Oh BJ, Shin JH, Kim MN, Sung H, Lee K, Joo MY, et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol. 2011;49(1):98-102. doi: 10.3109/13693786.2010.493563.
  • 3. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41-4. doi: 10.1111/j.1348-0421.2008.00083.x. [PubMed: 19161556].
  • 4. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48(6):e57-61. doi: 10.1086/597108. [PubMed: 19193113].
  • 5. Morales-Lopez SE, Parra-Giraldo CM, Ceballos-Garzon A, Martinez HP, Rodriguez GJ, Alvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23(1):162-4. doi: 10.3201/eid2301.161497. [PubMed: 27983941]. [PubMed Central: PMC5176232].
  • 6. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134-40. doi: 10.1093/cid/ciw691. [PubMed: 27988485]. [PubMed Central: PMC5215215].
  • 7. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670-3. doi: 10.3201/eid1910.130393. [PubMed: 24048006]. [PubMed Central: PMC3810747].
  • 8. Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother. 2017;61(6). doi: 10.1128/AAC.00485-17. [PubMed: 28416539]. [PubMed Central: PMC5444165].
  • 9. Sarma S, Upadhyay S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist. 2017;10:155-65. doi: 10.2147/IDR.S116229. [PubMed: 28652784]. [PubMed Central: PMC5476417].
  • 10. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(1). doi: 10.1186/s13756-016-0132-5.
  • 11. Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, et al. Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50(11):3641-51. doi: 10.1128/jcm.02248-12. [PubMed: 22952266]. [PubMed Central: PMC3486233].
  • 12. Sharma C, Kumar N, Meis JF, Pandey R, Chowdhary A. Draft genome sequence of a fluconazole-resistant Candida auris strain from a candidemia patient in India. Genome Announc. 2015;3(4). doi: 10.1128/genomeA.00722-15. [PubMed: 26184929]. [PubMed Central: PMC4505117].
  • 13. Chatterjee S, Alampalli SV, Nageshan RK, Chettiar ST, Joshi S, Tatu US. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015;16:686. doi: 10.1186/s12864-015-1863-z. [PubMed: 26346253]. [PubMed Central: PMC4562351].
  • 14. Chowdhary A, Sharma C, Meis JF. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13(5). e1006290. doi: 10.1371/journal.ppat.1006290. [PubMed: 28542486]. [PubMed Central: PMC5436850].
  • 15. Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, et al. The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61(5). doi: 10.1128/AAC.02396-16. [PubMed: 28223375]. [PubMed Central: PMC5404565].
  • 16. Britz E, Govender NP. Global emergence of a multi-drug resistant fungal pathogen,Candida auris. Southern Africa J Infect Dis. 2016;31(3):69-70. doi: 10.1080/23120053.2016.1221613.
  • 17. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol. 2015;53(6):1823-30. doi: 10.1128/JCM.00367-15. [PubMed: 25809970]. [PubMed Central: PMC4432077].
  • 18. Centers for Disease Control and Prevention. Clinical alert to US healthcare facilities-June 2016: Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. Atlanta: CDC; 2017, [cited 2016 Jul 29]. Available from: https://www.cdc.gov/fungal/candida-auris/candida-auris-alert.html.
  • 19. Klevens RM, Edwards JR, Richards CJ, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-6. doi: 10.1177/003335490712200205. [PubMed: 17357358]. [PubMed Central: PMC1820440].
  • 20. Schwartz IS, Hammond GW. First reported case of multidrug-resistant Candida auris in Canada. Can Commun Dis Rep. 2017;43(7-8):150-3. [PubMed: 29770082]. [PubMed Central: PMC5764715].
  • 21. Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41(2):285-95. doi: 10.1007/s00134-014-3603-2. [PubMed: 25510301].
  • 22. Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328-31. doi: 10.3201/eid2302.161320. [PubMed: 28098553]. [PubMed Central: PMC5324806].
  • 23. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139-42. doi: 10.1128/JCM.00319-11. [PubMed: 21715586]. [PubMed Central: PMC3165631].
  • 24. Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369-74. doi: 10.1016/j.jinf.2016.07.008. [PubMed: 27452195].
  • 25. Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other candida species. Infect Control Hosp Epidemiol. 2017;38(9):1107-9. doi: 10.1017/ice.2017.127. [PubMed: 28693657].
  • 26. Moore G, Schelenz S, Borman AM, Johnson EM, Brown CS. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J Hosp Infect. 2017;97(4):371-5. doi: 10.1016/j.jhin.2017.08.019. [PubMed: 28865738].
  • 27. Al-Siyabi T, Al Busaidi I, Balkhair A, Al-Muharrmi Z, Al-Salti M, Al'Adawi B. First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases. J Infect. 2017;75(4):373-6. doi: 10.1016/j.jinf.2017.05.016. [PubMed: 28579303].
  • 28. Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, et al. Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol. 2017;55(2):638-40. doi: 10.1128/JCM.02202-16. [PubMed: 27881617]. [PubMed Central: PMC5277535].
  • 29. Girard V, Mailler S, Chetry M, Vidal C, Durand G, van Belkum A, et al. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses. 2016;59(8):535-8. doi: 10.1111/myc.12519. [PubMed: 27292939].
  • 30. Raiesi O, Siavash M, Mohammadi F, Chabavizadeh J, Mahaki B, Maherolnaghsh M, et al. Frequency of cutaneous fungal infections and azole resistance of the isolates in patients with diabetes mellitus. Adv Biomed Res. 2017;6:71. doi: 10.4103/2277-9175.191003. [PubMed: 28626746]. [PubMed Central: PMC5468785].
  • 31. Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, Bernal-Martinez L, Cuesta I, Buitrago MJ, et al. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the sensititre yeast one and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. J Clin Microbiol. 2010;48(5):1782-6. doi: 10.1128/JCM.02316-09. [PubMed: 20220169]. [PubMed Central: PMC2863906].
  • 32. Shin JH, Kim MN, Jang SJ, Ju MY, Kim SH, Shin MG, et al. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol. 2012;50(6):1852-5. doi: 10.1128/JCM.06440-11. [PubMed: 22442324]. [PubMed Central: PMC3372122].
  • 33. Berkow EL, Angulo D, Lockhart SR. In vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical isolates of Candida auris. Antimicrob Agents Chemother. 2017;61(7). doi: 10.1128/AAC.00435-17. [PubMed: 28483955]. [PubMed Central: PMC5487607].
  • 34. Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, et al. In vitro interactions of echinocandins with triazoles against multidrug-resistant Candida auris. Antimicrob Agents Chemother. 2017;61(11). doi: 10.1128/AAC.01056-17. [PubMed: 28848002]. [PubMed Central: PMC5655075].
  • 35. Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-derived transmission of Candida auris during lung transplantation. Clin Infect Dis. 2017;65(6):1040-2. doi: 10.1093/cid/cix460. [PubMed: 28520901].
  • 36. Choi HI, An J, Hwang JJ, Moon SY, Son JS. Otomastoiditis caused by Candida auris: Case report and literature review. Mycoses. 2017;60(8):488-92. doi: 10.1111/myc.12617. [PubMed: 28378904].
  • 37. Kumar D, Banerjee T, Pratap CB, Tilak R. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries. 2015;9(4):435-7. doi: 10.3855/jidc.4582. [PubMed: 25881537].
  • 38. Khillan V, Rathore N, Kathuria S, Chowdhary A. A rare case of breakthrough fungal pericarditis due to fluconazole‐resistant Candida auris in a patient with chronic liver disease. JMM Case Rep. 2014;1(3). doi: 10.1099/jmmcr.0.T00018.
  • 39. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445-52. doi: 10.1128/JCM.00630-17. [PubMed: 28539346]. [PubMed Central: PMC5527423].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments